Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Works of D S Thompson being referenced
Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.
1986
Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy.
1980
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| D S Thompson | 425 | 101 | 90 | 17 | 516 | |
| Elizabeth Lee Lewandrowski | 315 | 83 | 127 | 28 | 530 | |
| J. Lekakis | 423 | 76 | 69 | 19 | 595 | |
| Murray A. Varat | 259 | 95 | 119 | 11 | 591 | |
| Alfred J. Kaltman | 304 | 110 | 88 | 16 | 469 | |
| Yuri Belenkov | 373 | 85 | 40 | 14 | 477 | |
| Leandra J M Boonman-de Winter | 241 | 79 | 54 | 15 | 513 | |
| Kazuya Sano | 342 | 116 | 157 | 21 | 467 | |
| Solomon Behar | 371 | 87 | 77 | 16 | 518 | |
| Shirley C. Seagren | 385 | 62 | 65 | 16 | 580 | |
| Masashi Kambayashi | 456 | 85 | 101 | 16 | 501 |
All Works
Loading papers...